Previous studies have shown that ATH434 promotes cellular iron efflux, reduces excess brain iron and aggregated α-synuclein, improves neuronal survival, and restores motor performance in murine PD and MSA models. The gene discussed is SNCA; the disease is multiple system atrophy.